| May 1 |
Progenics Announces Positive Results in Clinical Trial of Novel HIV
Therapy |
| May 1 |
Amsterdam Molecular Therapeutics BV to present preclinical
proof-of-concept data on its gene therapy AMT-020 to treat acute
intermittent porphyria |
| May 1 |
deCODE Announces Positive Topline Results for Phase I Study of
DG051 for the Prevention of Heart Attack |
| May 1 |
AVI BioPharma Reports Positive Pre-Clinical Influenza Data |
| May 1 |
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response
Against Hepatitis B Antigen in Animals |
| May 1 |
Peramivir Protects Mice From Lethal H5N1 Infection |
| May 1 |
Cephalon Presents Positive Results for Fentora in Breakthrough Pain
Associated with Neuropathic Conditions |
| May 1 |
New Research Results Show That Investigational Drug Phenoxodiol
Targets Cancer Protein, Causing Cancer Cell Death |
| May 1 |
Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple
Sclerosis Presented at the American Academy of Neurology |
| May 1 |
Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple
Sclerosis Presented at the American Academy of Neurology |
| May 1 |
Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia
Long-Term Safety Data at AAN Annual Meeting |
| May 1 |
FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,
FDA Regulations |
| May 1 |
Laquinimod, a Novel Oral Compound, Showed Significant Reduction in
Disease Activity in Patients with Relapsing-Remitting Multiple
Sclerosis (RRMS) |
| May 1 |
Researchers Urge Caution in Using ESAs for Cancer-Related Anemia |
| May 1 |
First of Its Kind Data Show: Immediate Treatment of Early MS
Patients with Betaseron Significantly Delayed Permanent Disability |
| May 2 |
Lyrica Significantly Reduced Pain and Helped Patients Manage the
Symptoms of Fibromyalgia, Data Show |
| May 2 |
Phase III Data on Safinamide in Parkinson’s Disease Presented
at American Academy of Neurology 59th Annual Meeting |
| May 2 |
MabThera Significantly Increases Survival of Lymphoma Patients
Regardless of Chemotherapy Regimen |
| May 2 |
Pediatric Academic Societies' Annual Meeting to Feature Data
Presentations Related to MedImmune Clinical Programs in Influenza,
RSV and hMPV |
| May 2 |
Drug for Treatment of Heart Failure Does Not Improve Survival,
Compared to More Widely-used Medication |
| May 2 |
Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic
Colorectal Cancer Patients Published |
| May 2 |
Immediate Treatment of Early MS Patients with Betaferon
Significantly Delayed Permanent Disability |
| May 2 |
Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than
Vaccines Used in Previous Years |
| May 2 |
FDA Proposes New Warnings About Suicidal Thinking, Behavior in
Young Adults Who Take Antidepressant Medications |
| May 2 |
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb
Trial of NicVAX |
| May 2 |
Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year
Alemtuzumab in Multiple Sclerosis Data Presented at AAN |
| May 2 |
Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across
Multiple Migraine Attacks |
| May 2 |
Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both
Traditional and Non-traditional Migraine Symptoms |
| May 2 |
Accera, Inc. Announces Results of Phase II Study in Alzheimer's
Disease at American Academy of Neurology Meeting |
| May 2 |
St. Jude Study Shows Effectiveness of Peramivir in Prevention of
Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection |
| May 2 |
Cethromycin Shown Effective Against Anthrax in Study |
| May 2 |
New Critical Path Report Highlights Research Needed to Foster
Generic Drug Development |
| May 2 |
Pluristem to Present Two Scientific Posters at the International
Society for Cellular Therapy |
| May 2 |
LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic
Protection Against Influenza Challenge With Virus-Like Particle
Immunization |
| May 2 |
New Data Shows Once a Day Lamictal XR is Effective in Treating
Patients with Partial Seizures |
| May 3 |
Once-yearly Reclast Significantly Reduced Bone Fractures in Women
with Postmenopausal Osteoporosis |
| May 3 |
Data Suggest Cymbalta Reduced Severity of Night Pain in Patients
with Diabetic Nerve Pain |
| May 3 |
Indivumed Study Provides Sound Scientific Basis for a Predictive
Drug Test- Platform |
| May 3 |
Data Presented at the American Academy of Neurology's Annual
Meeting Provide Update on Utilization and Safety of Tysabri in
Patients with Multiple Sclerosis |
| May 3 |
YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets
Primary Endpoint in Patients with Post-Surgical Pain |
| May 3 |
Studies Presented at Neurology Conference Highlight Early Efficacy,
Long-Term Tolerability, and High Patient Satisfaction with
Betaseron |
| May 3 |
Insmed Announces Promising Results From IPLEX Phase II Myotonic
Muscular Dystrophy Clinical Study |
| May 3 |
Quest PharmaTech's Prostate Cancer Program Update |
| May 3 |
Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical
Trial in Second Quarter |
| May 3 |
Alpharma Presents Positive Pharmacokinetic Study Results of Its
Investigational Abuse-Deterrent, Extended-Release Opioid |
| May 3 |
Novavax Reports Positive Pre-Clinical Study Results from Live Virus
Challenge to Pandemic Flu Vaccine |
| May 3 |
Xanthus Presents Novel Approach for Autoimmune Disease Reversal
with Symadex |
| May 3 |
Acorda Therapeutics Presents Data from its Phase 3 Study of
Fampridine-SR in Multiple Sclerosis at the American Academy of
Neurology Meeting |
| May 3 |
ANX-201 Drug Combination Demonstrates Synergistic Activity Against
Human and Bird Flu Viruses |
| May 3 |
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the
Treatment of Alzheimer's Disease |
| May 3 |
Revolutionary Immunologic Data Explains Function of Diamyd Diabetes
Vaccine |
| May 3 |
EpiCept Corporation to Present New NP-1 Data at American Pain
Society Meeting |
| May 3 |
Genelabs Technologies Announces Presentation of Data on
Non-Nucleoside HCV Polymerase Inhibitor at 20th International
Conference on Antiviral Research Meeting |
| May 3 |
Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro
Studies for Promising Alzheimer's Drug |
| May 4 |
Inspire Announces Presentations at 2007 Association for Research in
Vision and Ophthalmology Annual Meeting |
| May 4 |
Argos Therapeutics Presents Immunosuppression Data for Soluble CD83
at the American Society of Transplantation Congress 2007 |
| May 4 |
Treatment with Copaxone Plus Minocycline Showed Substantial
Reduction of Disease Activity in Patients with Active
Relapsing-Remitting Multiple Sclerosis |
| May 4 |
Data to be presented at AAN Meeting -Study results of drug
candidate for MS |
| May 4 |
Abbott's Investigational Treatment ABT-874 Shows Positive Results
in Phase II Psoriasis Study |
| May 4 |
Clinical Trial Results Suggest Long-Term Treatment Benefit of
Tetrabenazine for Chorea Associated with Huntington's Disease |
| May 4 |
Copaxone Treatment over Two Years after Short Term Induction with
Mitoxantrone Provided Sustained Benefits to Active
Relapsing-Remitting Multiple Sclerosis Patients |
| May 4 |
Treatment with Copaxone Plus Minocycline Showed Substantial
Reduction of Disease Activity in Patients with Active
Relapsing-Remitting Multiple Sclerosis |
| May 4 |
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data
From Nerve Regeneration Program at American Society for Neural
Therapy and Repair Meeting |
| May 4 |
PTC Therapeutics Announces Additional Positive Interim Phase 2
Results of PTC124 in Duchenne Muscular Dystrophy |
| May 4 |
Medivation Announces Presentation of New Subset Analyses From
Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of
Neurology Annual Meeting |
| May 4 |
Lux Biosciences' Investigational Therapy for Uveitis, LX211, is
Subject of Two Presentations at Key Ophthalmology Meeting, ARVO
2007 |
| May 4 |
Independent publication supports the profile of CeNeS phase II
compound, CNS 5161 |
| May 4 |
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device
Combination Product - ChronoDose |
| May 4 |
Isotechnika's Lead Drug, ISA247, To Be Highlighted at the
Association for Research in Vision and Ophthalmology (ARVO) Annual
Meeting |
| May 7 |
IR BioSciences Announces Promising Data from Study of Its Compound
Homspera |
| May 7 |
NanoViricides Drugs Found To Be Highly Effective Against Most
Recent Strain of the H5N1 Avian Flu Virus |
| May 7 |
Alba Therapeutics Corporation Reports Preliminary Phase IIa
Clinical Trial Results for AT-1001 for the Treatment of Celiac
Disease |
| May 7 |
Alnylam Reports Results of Human Experimental Infection Model with
Respiratory Syncytial Virus |
| May 7 |
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent
Trial Conclusions |
| May 7 |
Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting |
| May 7 |
Pacgen Announces Positive Results from Phase I/II Trial of Novel
Antifungal Drug |
| May 7 |
Early Results of the CellCept Spare the Nephron Study Examine
Kidney Function |
| May 7 |
Preterm Infants with Respiratory Distress Syndrome: Incidence Rates
of Death when Treated with Surfactant Replacement Therapies |
| May 7 |
OXiGENE Announces a Poster Presentation Highlighting Results from
its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study
MMD-213) at the 47th Annual Meeting of the Association of Research
in Vision and Ophthalmology |
| May 7 |
FDA Advises Manufacturers to Test Glycerin for Possible
Contamination |
| May 7 |
Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In
Absolute Bioavailability Study |
| May 7 |
Pixantrone Granted Fast Track Designation by FDA for Relapsed
Indolent NHL Patients |
| May 7 |
Isotechnika Announces Interim Three Month Data from Phase 2b Kidney
Transplant Trial |
| May 8 |
Inspire Announces Positive Results of Phase 2 Trial of Epinastine
Nasal Spray for Seasonal Allergic Rhinitis |
| May 8 |
Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric
Academic Societies' Annual Meeting |
| May 8 |
King Pharmaceuticals Announces Plan to Present Results from Phase
III Clinical Trial Evaluating ALTACE as Monotherapy and in
Combination with Hydrochlorothiazide at the American Society of
Hypertension Annual Meeting |
| May 8 |
ISTA Pharmaceuticals Announces Statistically Significant
Preliminary Results From its U.S. Phase II/III Clinical Study Of
Bepotastine |
| May 8 |
AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic
Peripheral Neuropathic Pain at Second International Congress on
Neuropathic Pain |
| May 8 |
Data Show FluMist May Reduce Seasonal Influenza Burden Among
Children in School, Daycare Settings |
| May 8 |
MedImmune Announces Positive Clinical Results at PAS Annual Meeting
From Large Prospective Trial in Prevention of Serious RSV Disease |
| May 8 |
Multiferon Shows Potent Activity in Preventing the Progression of
Malignant Melanoma; Study to be Published |
| May 9 |
Wyeth Presents Phase 3 Data for Pristiq, an Investigational
Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats |
| May 9 |
FDA Re-Inspection Results in Positive Re-Classification of Guayama
Facility |
| May 9 |
Discovery's KL-4 Surfactant Technology Demonstrates Novel
Anti-Inflammatory Properties |
| May 9 |
Palatin Technologies and King Pharmaceuticals Announce Plan To
Present Results of Bremelanotide Phase 2b Studies in Men With
Erectile Dysfunction |
| May 9 |
Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be
Presented at American Thoracic Society International Conference |
| May 9 |
Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results
of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's
Investigational Drug to Treat Cocaine and Methamphetamine Addiction |
| May 9 |
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual
Meeting |
| May 9 |
Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type
Disasters; House Urged to Act on Strong Drug Safety Bill |
| May 10 |
Repligen Reports Positive Phase 2 Clinical Trial Results of
Secretin for MRI Imaging of the Pancreas |
| May 10 |
New England Journal of Medicine Publishes New Data on Gardasil,
Merck's Cervical Cancer Vaccine |
| May 10 |
Gardasil Demonstrates Up to 100% Efficacy |
| May 10 |
Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate
Dependency Treatment Are Mothers |
| May 10 |
New Position Statement from The North American Menopause Society
Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in
Postmenopausal Women |
| May 10 |
Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor
AP 12009 to be Presented |
| May 10 |
FDA Announces Results of Investigation Into Illegal Promotion of
OxyContin by The Purdue Frederick Company, Inc. |
| May 10 |
GenVec Presents Research on New Ad35 Adenovector at ARVO |
| May 10 |
KineMed Presents Data Measuring Changes in Reverse Cholesterol
Transport for the First Time |
| May 10 |
2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with
AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion |
| May 11 |
NicOx Provides an Update on the Phase 2a Study for NCX 1000
Conducted With Axcan |
| May 14 |
GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets
Phase II Study Endpoints of Immunogenicity and Safety Compared to
Licensed Vaccines |
| May 14 |
Actilyse (alteplase) Recommended by National Institute for Health
and Clinical Excellence for Treatment of Acute Ischaemic Stroke |
| May 14 |
Oculus Innovative Sciences Microcyn Technology Presented in Poster
at European Wound Management Association Conference |
| May 14 |
Global Rabies Treatment May be Possible with NanoViricides Drugs |
| May 14 |
Sciele Pharma Announces Successful Completion of New Sular
Formulation Clinical Trial Program |
| May 14 |
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for
Bema Fentanyl |
| May 14 |
Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in
Preclinical Studies |
| May 14 |
Nationally Recognized Researchers Provide First Economic
Projections of Social Value of Treatments That Delay Onset of
Alzheimer's Disease |
| May 14 |
Shire to Present New Scientific Data on ADHD Treatment Portfolio at
APA Annual Meeting |
| May 14 |
New Study Reveals Limitations of a Complex and Challenging Global
Tuberculosis Drug Marketplace |
| May 15 |
Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in
Preclinical Studies |
| May 15 |
SkyePharma and Sciele Pharma Announce Successful Completion of New
Sular Formulation Clinical Trial Programme |
| May 15 |
Survey: Migraine Patients Taking Potentially Addictive Barbiturate
or Opioid Medications Not Approved by FDA as Migraine Treatments |
| May 15 |
SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 |
| May 15 |
New Survey Finds Troubling Data on American Asthma Sufferers |
| May 15 |
Gemin X Biotechnologies Announces Publication in Blood of Positive
Preclinical Data of Lead Compound in Mantle Cell Lymphoma |
| May 15 |
Boston Scientific Announces Schedule for EuroPcr 2007 |
| May 15 |
Positive results from placebo-controlled phase IIa study in
patients suffering from house dust mite allergy |
| May 15 |
Geron Corp. Licensee TA Sciences Announces Proven Anti-Aging
Benefits of TA-65, Their Telomerase Activator: Improved Immune
Function, Vision, Skin, Male Sexual Function, Well-Being &
Energy are Strongest Claims |
| May 15 |
First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A)
Significantly Improves Idiopathic Detrusor Overactivity (IDO) in
Patients With Symptoms of Overactive Bladder |
| May 15 |
RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds
Significant Promise for Treating Breast Cancer |
| May 16 |
Positive Statistical Analysis from Synthetic Blood's Oxycyte
Traumatic Brain Injury Trial Indicates Achievement of Primary
Endpoint |
| May 16 |
Gloucester Pharmaceuticals Receives Fast Track Designation for
Romidepsin in Peripheral T-Cell Lymphoma |
| May 16 |
AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1
Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV
Irradiated Skin Cells |
| May 16 |
The International Myeloma Foundation Reports Positive Shift In
Treatment Paradigm For Patients |
| May 17 |
Oxford Biomedica Announces That Phase II Results with Hi-8 Mel in
Melanoma Will Be Presented at American Association of Immunologists
Meeting |
| May 17 |
DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan
PDT to Treat Esophage al Dysplasia |
| May 17 |
Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS
301012 in Familial Hypercholesterolemia Patients |
| May 17 |
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many
Aspects of Daily Life |
| May 17 |
ProtoKinetix' AAGP Improves Effectiveness of Diabetes Treatment |
| May 17 |
AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin
Cells Have the Ability to Recognize, Transport and Utilize
L-ergothioneine (EGT) As A Protector Against Oxidative Damage |
| May 17 |
Pro-Pharmaceuticals to Present Abstract at the International
Society of Oncodevelopmental Biology and Medicine Conference |
| May 17 |
Salix Pharmaceuticals Previews Digestive Disease Week 2007 |
| May 17 |
Inovio Biomedical's Partners to Present New Data from Two Cancer
Immunotherapy Clinical Trials |
| May 17 |
Clinical Trial Data for Perforomist Inhalation Solution to be
Presented at ATS on May 20, 2007 |
| May 17 |
BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming
Clinical Conferences |
| May 17 |
Study Continues to Show Patients With Myelodysplastic Syndromes
Treated With Revlimid are Living Longer and Remaining Transfusion
Independent |
| May 18 |
DURECT Provides an Update to the Memryte Program Under Development
by Voyager Pharmaceutical Corp |
| May 18 |
Data Published in The Lancet Show Gardasil was 100 Percent
Effective in Preventing High-Grade Vulvar and Vaginal Lesions
Caused by HPV Types 16 and 18 |
| May 18 |
Staphylococcus aureus vaccine development on track ? safe and
immunogenic in Phase I clinicaltrials |
| May 18 |
Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical
Potential |
| May 18 |
Migenix to Present Celgosivir Phase II Hepatitis C Results at
Digestive Disease Week 2007 |
| May 18 |
Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical
Potential |
| May 18 |
Schering-Plough Announces Hepatitis C Data Presentations at
Digestive Disease Week (DDW) 2007 Annual Meeting |
| May 18 |
Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007
American Psychiatric Association Annual Meeting |
| May 21 |
InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive
Disease Week Meeting |
| May 21 |
Innovative Cancer Drug MabThera Again Shown To Improve Survival
Rates In Patients With Lymphoma |
| May 21 |
Amlodipine and Olmesartan Study Results Released; Late Breaker
Presented at American Society of Hypertension Twenty-Second Annual
Scientific Meeting (ASH 2007) |
| May 21 |
Data Suggest that Pegasys May be an Option in Hepatitis C Patients
Unable to Tolerate Peg-Intron |
| May 21 |
New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory
Properties and Increased Health Benefits |
| May 21 |
King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy
of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For
24-hour Blood Pressure Control |
| May 21 |
New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard
Therapy in Treatment of Hypertension |
| May 21 |
Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin
in Complicated Urinary Tract Infections and Acute Pyelonephritis |
| May 21 |
Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load
Reduction Compared to Adefovir at 48 Weeks in Study of
Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients |
| May 21 |
Clinical Trial Data for Perforomist (Formoterol Fumarate)
Inhalation Solution Presented at International ATS Conference |
| May 21 |
Dendreon Announces Presentation of Data at American Urological
Association Annual Meeting |
| May 21 |
Exforge Helps Vast Majority of Patients Effectively Control Their
Blood Pressure After Failing on Other Medicines, According to New
Clinical Data |
| May 21 |
Efficacy and Safety Profile of Basilea's Alitretinoin for Severe
Refractory Chronic Hand Eczema Confirmed by Data Shown at European
Dermatology Congress |
| May 21 |
Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage
2 Patients Compared With Amlodipine + Benazepril |
| May 21 |
Microbia Announces Positive Phase 2 Results for Its Investigational
Compound Linaclotide |
| May 21 |
Cougar Biotechnology Announces Presentation of Positive CB7630
Clinical Data at AUA Annual Meeting |
| May 21 |
New Study Demonstrates that Lubiprostone May Improve Symptom Relief
Rates in Adults with Irritable Bowel Syndrome with Constipation
(IBS-C) |
| May 21 |
Hypertension Education Foundation Survey Results Announced At
American Society For Hypertension Annual Meeting Suggests Improved
Control Of High Blood Pressure, But Misconceptions Still Exist |
| May 21 |
Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure
as Long-Term Monotherapy and in Combination Therapy |
| May 21 |
CEL-SCI Presents Long-Term Cancer Survival Data With Multikine |
| May 21 |
Independent Publication Confirms Growing Therapeutic Challenge of
T315I Mutation in Patients with CML, Notes ChemGenex |
| May 21 |
Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free
Survival by 45 Percent in Patients With Intermediate-Risk Kidney
Cancer |
| May 21 |
Nektar Threraputics Announces Phase 2a Clinical Results Regarding
the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative
Hospital-Acquired Pneumonia Presented at the Annual American
Thoracic Society International Conference |
| May 21 |
Clinical Trial Data for Perforomist (Formoterol Fumarate)
Inhalation Solution Presented at International ATS Conference |
| May 21 |
Gilead Announces Presentation of Long-Term Data for Ambrisentan, a
Potential Treatment for Patients With Pulmonary Arterial
Hypertension |
| May 21 |
Intarcia Therapeutics Announces Presentation of Final Results From
a Phase 2 Combination Study for the Treatment of Hepatitis C at the
Digestive Disease Week Conference |
| May 21 |
Independent Publication Confirms Growing Therapeutic Challenge of
T315I Mutation in Patients with CML, Notes ChemGenex |
| May 21 |
Alterations in Intestinal Serotonin in Irritable Bowel Syndrome and
Dyspepsia |
| May 21 |
FDA Issues Safety Alert on Avandia |
| May 21 |
Pegasys Study Authors Conclude that Patients Successfully Treated
for Hepatitis C Can be Considered ''Cured'' |
| May 21 |
Data Suggest Cymbalta Improved Functioning in Patients with
Generalized Anxiety Disorder |
| May 22 |
Additional Efficacy Data from Satraplatin SPARC Phase 3
Investigational Trial Presented at Annual Meeting of American
Urological Association |
| May 22 |
New Study Results Provide Additional Data about Short- and
Long-Term Use of Desvenlafaxine Succinate in the Treatment of
Adults with Major Depressive Disorder |
| May 22 |
Organon's Asenapine Effective in a Phase III Study for the
Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA
Meeting |
| May 22 |
Pooled Studies Showed Desvenlafaxine Succinate Significantly
Improved Painful Symptoms and Anxious Symptoms Associated with
Major Depressive Disorder in Adults, Compared With Placebo |
| May 22 |
Six-Week Investigational Study In Adults With Major Depressive
Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole
Therapy With Antidepressants |
| May 22 |
UCB Presents Long-Term CImzia Data in Crohn's Disease |
| May 22 |
New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At
Annual Digestive Disease Week Meeting |
| May 22 |
Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term
Safety Study of Lialda (mesalamine) Presented at DDW |
| May 22 |
PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007
Digestive Disease Week |
| May 22 |
New Analysis of Data Shows Treatment With Abbott's Humira
(Adalimumab) Significantly Reduced Disease-Related Hospitalization
for Patients with Crohn's Disease |
| May 22 |
Separate Sets of Research Show Treatment Improved Quality of Life
in as Early as Three Weeks; Patient Adherence to Medication is
Multifactorial |
| May 22 |
Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral
Approach to Treating Inflammatory Diseases |
| May 22 |
Auxilium Announces New Data That Show Total Testosterone Blood
Levels Increase Significantly Following Switch from AndroGel(R) to
Testim(R) |
| May 22 |
BioLineRx Presents Data From Successful Phase I Trial for BL-1020
in Schizophrenia at American Psychiatric Association Conference |
| May 22 |
NanoBio Corporation Announces Positive Phase 1 Clinical Results for
Topical Treatment for Onychomycosis |
| May 22 |
Sosei Announces Successful Completion of AD 923 Pharmacokinetic
Study in the USA |
| May 22 |
Inovio: DNA delivery technology shows positive human results |
| May 22 |
Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes
for Moderate-Release Paclitaxel-Eluting Stent at Four Years |
| May 22 |
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis
in Real-World Use of Drug-Eluting Stents |
| May 22 |
NCCN Updates Esophageal and Gastric Cancer Guidelines |
| May 22 |
ACC Sanctions Leon |
| May 22 |
Enzo Biochem Individualized Oral Immune Regulation Therapy May Be
Effective Approach to Treating Crohn's Disease |
| May 22 |
Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to
Bypass Surgery and Better Outcomes Than Bare Metal Stents in
Subgroup Analysis of Diabetic Patients With Multivessel Coronary
Disease |
| May 22 |
Abbott Announces Positive Nine-Month Results From the World's First
Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent |
| May 22 |
Abbott Announces Continued Positive Results with Xience V
Everolimus Eluting Coronary Stent in Spirit Clinical Trials |
| May 22 |
New Long-Term Data Analyses for Bifeprunox Show Favorable Effects
Versus Placebo in Stabilized Patients with Schizophrenia |
| May 22 |
Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug
Candidate, Sphingomab |
| May 22 |
Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial
Results at EuroPCR 2007 |
| May 22 |
Medtronic Announces Positive Nine-Month Results for Endeavor
Resolute Next Generation Drug-Eluting Stent at EuroPCR |
| May 22 |
SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus
Drug-Eluting Coronary Stent Systems |
| May 22 |
Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing
Sustained Safety and Significant Reductions in Repeat Procedures |
| May 22 |
XTENT Announces Promising Six-Month Custom II Trial Data Presented
at EuroPCR Meeting |
| May 22 |
Antipsychotic Iloperidone Results Show Favorable Akathisia Profile |
| May 22 |
New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release
Tablets as Effective Treatment for Schizophrenia |
| May 22 |
Blood Levels of Paliperidone Extended-Release Tablets are Not
Increased by Common Antidepressant |
| May 23 |
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce
Positive Results of Phase III Study for Milnacipran as a Treatment
for Fibromyalgia Syndrome |
| May 23 |
Pharmacyclics Announces Presentations and Published Abstracts on
Xcytrin at The 2007 American Society of Clinical Oncology Annual
Meeting |
| May 23 |
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at
Annual Meeting of American Urological Association |
| May 23 |
AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2
Data for Ozarelix, in BPH at Annual AUA Meeting |
| May 23 |
Northfield Laboratories Reports Results of Pivotal Phase III Trauma
Study |
| May 23 |
ProtoKinetix's AAGP Dramatically Increases Recovery Rate of
Cryopreserved Stem Cells |
| May 23 |
Cytogen Reports Publication Validating the Utility of its
Proprietary ProChart Database |
| May 23 |
Making Science Personal: Lilly Oncology to Unveil 76 Studies at
ASCO 2007 |
| May 23 |
MIV Therapeutics Announces Renowned Researcher to Detail Milestone
Pre-Clinical Results at Prominent International Conference EuroPCR
2007 |
| May 23 |
CytoGenix to Present at 2007 International DNA Vaccines Conference
in Spain |
| May 23 |
Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA
Vaccine Performance; Yields Antibody Responses Comparable to
Electroporation Without Tolerability Issues |
| May 23 |
Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from
2006 Presented at Digestive Disease Week in Washington, D.C. |
| May 23 |
Poniard Pharmaceuticals Announces Clinical Data from Picoplatin
Phase 2 Small Cell Lung Cancer Trial To Be Presented at American
Society of Clinical Oncology Annual Meeting |
| May 23 |
Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares
Favorably to Drug-Eluting Stents |
| May 23 |
Aquavan (Fospropofol Disodium) Injection Data Presented at
Digestive Disease Week 2007 |
| May 23 |
Palatin Technologies and King Pharmaceuticals Report Data Showing
Improvements in Sexual Relationship and Self-Esteem in Patients
with Erectile Dysfunction Treated with Bremelanotide |
| May 23 |
New Study Suggests no Significant Impairment in Middle-of-the-Night
Balance, Mobility or Memory in Older Adults Using Ramelteon |
| May 23 |
Neurogen Proprietary Insomnia Compound Data Presented at American
Psychiatric Association Annual Meeting |
| May 23 |
Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of
Docetaxel Chemotherapy |
| May 23 |
VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine
Candidates Trigger Robust Immune Responses and Protection in
Pre-Clinical Models |
| May 23 |
New Data Suggests Less Abuse-Related Effects For OROS
Methylphenidate |
| May 23 |
CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response
Against Avian Flu Antigen in Animals |
| May 23 |
Amlodipine and Olmesartan Study Results Released;Late Breaker
Presented at American Society of Hypertension Twenty-Second Annual
Scientific Meeting (ASH 2007) |
| May 23 |
Acusphere Announces Publication on Imagify in the Journal Future
Drugs |
| May 23 |
New Data Focuses on Abuse of Stimulant Medication |
| May 23 |
Synta Oncology Candidate STA-4783 Clinical Trial Results to Be
Presented at the ASCO Annual Meeting |
| May 23 |
Study Suggests Strattera Improved ADHD Symptoms in Patients With
Comorbid Alcohol Abuse |
| May 23 |
Long-Term Extension of Ulcerative Colitis Study Shows Remicade
Responders Maintained Improvement Through Two Years of Follow-Up |
| May 23 |
Daytrana (methylphenidate transdermal system) Provides Significant
Effectiveness in ADHD Symptom Relief in Both Boys and Girls |
| May 23 |
12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA
(methylphenidate transdermal system) |
| May 24 |
Bentley Late Breaking Abstract Accepted for Poster Presentation at
American Diabetes Association Scientific Sessions |
| May 24 |
La Jolla Pharmaceutical Company Reports Riquent Well Tolerated in
Three Studies at International Lupus Congress |
| May 24 |
Shire Announces Positive Results of Studies With Guanfacine
Extended Release, An Investigational Nonstimulant Medication Filed
for the Treatment of ADHD in Children and Adolescents |
| May 24 |
ChemoCentryx Presents Positive Phase 2 Clinical Data for
Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007
Conference |
| May 24 |
Investigational Study Evaluates the Effectiveness of Aripiprazole
in Adolescents With Schizophrenia |
| May 24 |
Inovio Biomedical's DNA Delivery Technology Shows Safety and
Enhances Gene Expression & Tumor Responses in Interim Melanoma
Clinical Study Results |
| May 24 |
Long-term Treatment with Vyvanse (lisdexamfetamine dimesylate), the
First Prodrug Stimulant, Demonstrates Significant Efficacy in
Children with ADHD |
| May 24 |
RX100 Rescues Life if Administered 3, 6, 12, or Up to 24 Hours
After Exposure to Lethal, Whole-Body Radiation! |
| May 24 |
In New Study, Duloxetine Was Equally Effective, Regardless of
Switch Method, in Reducing Painful Symptoms in Ssri Non- or
Partial-responders with Depression |
| May 24 |
Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for
the Treatment of Psoriasis |
| May 24 |
Proteolix Announces Interim Clinical Results with Carfilzomib to be
Reported at ASCO 2007 Annual Meeting |
| May 24 |
Anti-Interleukin-9 Data Presented at the American Thoracic Society
Meeting |
| May 24 |
MedImmune Highlights Advances in Inflammatory Disease Pipeline With
Series of Data Presentations |
| May 24 |
ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds
for Solid Tumors Are to be Reported at ASCO |
| May 24 |
Generex Biotechnology Vaccine Strategy Presented at International
Conference in London |
| May 24 |
Targanta Study Shows Oritavancin Treatment Effective in a Mouse
Model of Anthrax |
| May 25 |
GTx Announces Presentation of Ostarine and Acapodene Data at 2007
ASCO Annual Meeting |
| May 25 |
Iomai Announces Interim Results From Phase 1 Study of Its
Patch-Based Vaccine for Seasonal Influenza |
| May 25 |
Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be
Presented at the ASCO Annual Meeting |
| May 25 |
Clinical Trial Excellence: Shaping Markets Through Early
Communication of Clinical Trial Data |
| May 25 |
Limiting Eligibility for Medical Studies Can Omit Women,
African-Americans, Stanford Study Finds |
| May 25 |
Iomai to Announce Results From Phase 1 Influenza Trial and Host
Webcast Tomorrow |
| May 25 |
Viventia Biotech Reports Final Vicinium Phase I/II Bladder Cancer
Data at the American Urological Association Annual Meeting |
| May 25 |
Genta Incorporated to Present Multiple Abstracts at the Annual
Meeting of the American Society of Clinical Oncology |
| May 25 |
Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study
Results at the American Society of Clinical Oncology Annual Meeting |
| May 25 |
Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be
Presented at the ASCO Annual Meeting |
| May 29 |
Onyx Pharmaceuticals Announces an Analyst Briefing |
| May 29 |
New Pfizer Oncology Data Across Numerous Cancer Types to be
Presented at ASCO |
| May 29 |
Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have
Reduced Potential to Develop Resistance to Panacos' Bevirimat |
| May 29 |
Introgen and Clinical Collaborators to Report New Results with
Advanced-Stage Cancer Therapies at Upcoming Medical Meetings |
| May 29 |
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at
International Influenza Meeting |
| May 29 |
Antidepressant Use May Boost Fracture Risk, From Harvard Women's
Health Watch |
| May 29 |
Data to be Presented at ASCO 2007 Highlights sanofi-aventis
Commitment to Cancer Care and Research |
| May 29 |
Alfacell and University of Bath Collaborators Identify Structure of
Amphinase |
| May 29 |
Mild Asthma, a Revolutionary Therapy from Italian Research |
| May 29 |
Velcade (Bortezomib) for Injection to be Featured at Upcoming
American Society of Clinical Oncology Meeting |
| May 29 |
DP-b99 Phase IIb Trial Results to be Presented at the European
Stroke Conference |
| May 29 |
Investigation Findings, Corroborated by Empirical Evidence of the
Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine
for Hundreds of Years, Support the Use of Schisandrin B in the
Prevention and Treatment of IHD |
| May 29 |
Positive Final Data from HyCAMP Phase II Trial in Metastatic
Colorectal |
| May 30 |
Gilead Announces Achievement of Primary Efficacy Endpoint in Second
Phase III Study of Aztreonam Lysine for Inhalation in Patients With
Cystic Fibrosis |
| May 30 |
New Data Highlighting Abraxane as Single Agent and in Combination
for the Treatment of Breast, Lung and Ovarian Cancers to Be
Presented at ASCO |
| May 30 |
Innovive Pharmaceuticals to Present Interim Data from Phase I Study
of INNO-406 at the American Society of Clinical Oncology Annual
Meeting |
| May 30 |
Celldex Therapeutics Announces Poster Presentations of Lead Product
Candidates at ASCO Annual Meeting |
| May 30 |
Algeta to Present Phase II Clinical Study Data for Alpharadin in
Prostate Cancer at ASCO |
| May 30 |
Celsion Completes Enrollment in Phase I Liver Cancer Study |
| May 30 |
Introgen's Advexin Demonstrates Clinical Benefit in Inherited
Cancer |
| May 30 |
Inovio Biomedical to Present at American Society of Gene Therapy
Meeting |
| May 30 |
Array BioPharma to Present Clinical Data at the European League
Against Rheumatism (EULAR) Annual Meeting and the 8th World
Congress on Inflammation |
| May 30 |
Data from Rexahn Pharmaceuticals' Phase I Trial of RX-0201
(Archexin) to Be Presented at the 43rd American Society of Clinical
Oncology Annual Meeting in Chicago |
| May 31 |
Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard
Researcher |
| May 31 |
Hemispherx Presents Potential Avian Influenza Treatment
Breakthrough at Paris Conference |
| May 31 |
Six Abstracts Featuring Exelixis Compounds Accepted At ASCO
Conference |
| May 31 |
Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO
Annual Meeting |
| May 31 |
Data Published in the New England Journal of Medicine Showed
Torisel Extended Median Overall Survival for Patients with Advanced
Renal Cell Carcinoma |
| May 31 |
IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at
2007 ASCO Annual Meeting |
| May 31 |
Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology
Shown to Significantly Lower Instances of Severe Retinopathy of
Prematurity in Extremely Low Birth Weight Infants |
| May 31 |
OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO |
| May 31 |
Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term
Protection and Sterilizing Immunity in Nonhuman Primates |
| May 31 |
LifeCycle Pharma Announces Positive Phase I Clinical Results for
its Transplantation Product Candidate, LCP-Tacro |
| May 31 |
Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at
the American Headache Society Meeting |
| May 31 |
AMT Presents Positive Results of Phase I/II Study with Lead Product
at Annual Meeting of American Society of Gene Therapy |
| May 31 |
Review of Nexavar Data Presented at ASCO 2007- Investor Conference
Call on June 4, 2007 |
| May 31 |
Infinity and MedImmune Announce Updated Data On Ipi-504 to be
Presented At ASCO |
| May 31 |
New Research Confirms the Benefit of Extended-Release Dipyridamole
Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk
Patients |
| May 31 |
Presentations at 2007 European Stroke Congress Highlights New
Direction for Viprinex (ancrod) |
| May 31 |
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of
C1-Esterase Inhibitor for Hereditary Angioedema |
| May 31 |
Peregrine Pharmaceuticals Reports Positive Top-Line Results in
Bavituximab Combination Therapy Trial in Advanced Cancer Patients |
| May 31 |
Medicure's MEND-CABG Trial Results Published in Peer Reviewed
Journal |
| May 31 |
PARI and Kamada Announce Positive Intermediate Phase I Results for
Inhaled Alpha-1 Antitrypsin |
| May 31 |
Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators
Published in Pediatrics |
